Non-acid glycosphingolipids were isolated from small intestinal epithelial cells of a single blood group A pig. One very predominant blood group compound was obtained chemically pure upon HPLC fractionation. It was charac-: terized by mass spectrometry and *H NMR spectroscopy to be the type 1 chain blood group A hexaglycosylceramide. Support for the presence of minute amounts of additional A glycolipids was obtained by mass spectrometry and immunostaining of TLC plates with anti-A antibodies specific for A type 2 chain, A type 3 and 4 chain, and the ALe b determinant Among precursor chains, globoside (type 4) and Iactotetraosylceramide (type 1) were immunologically identified, whereas no neolactotetraosylceramide (type 2) and gangliotetraosylceramide reactivities were detected. We addressed the question whether the predominant expression of type 1 chain based A glycolipids reflects a restricted glycolipid precursor chain specificity of the al-2 fucosyland/or the al-3 N-acetylgalactosaminyltransferases, or if the biosynthesis of the precursor chains themselves is regulated. All precursor core saccharides, lacto-(type 1), neolacto-(type 2), and gangliotetraosylceramide as well as globopentaosylceramide (type 4), could serve as acceptors for fucose in vitro when a crude microsomal fraction obtained from mechanically released, porcine intestinal epithelial cells was used as an enzyme source. Under the same conditions an /V-acetylgalactosamine residue could be transferred to the blood group H structures based on these core saccharide chains. Lactotriaosylceramide, but not gangliotriaosylceramide, could serve as an acceptor for UDPgalactose. When the product was digested with Pgalactosidase (EC 3.2.1.23) from S.pneumoniae, under conditions where it specifically cleaves Gal 31-4 residues, approximately 40% of the radioactivity was cleaved off, indicating that a substantial amount of neolactotetraosylceramide was made in vitro, as opposed to the predominance, of lactotetraosylceramide-based structures found in vivo.
Introduction
Blood group A glycosphingolipids based on four (types 1-4) different core saccharide chains that are expressed in a tissuespecific manner have been identified in humans (reviewed in Holgersson et al., 1992) . Type 1 chain A glycolipids under the control of the Se and Le genes are predominantly found in endodermally derived tissues such as the mucosa of the gastrointestinal, respiratory, and urinary tracts, type 2 chain (-GalfJ l-4GlcNAc-) A glycolipids independent of the Se and Le genes are mainly found in mesodermally and ectodermaUy derived tissues such as epidermis, vascular endothelium and blood cells, while the only hitherto known blood group A glycolipid based on the type 4 chain (-Galpl3GalNAcf3-) predominates in the kidney-an organ with tissue elements from both endo-and ectoderm (Holgersson et al., 1992) . Type 3 chain (-Gal£l-3GalNAca-) A glycolipids have been identified in red blood cells, kidney, and vascular tissue (Holgersson et al, 1992) .
The factors determining the tissue-specific expression of ABH glycolipids with different chain types are largely unknown as is its physiological significance. However, some hypotheses may be put forward to account for this expression pattern. First, individual glycosyltransferases making up the A determinant, i.e., the al-2 fucosyl- Rouquier et al., 1995) and al-3 A'-acetylgalactosaminyltransferases (Yamamoto et aL, 1990a,b) , may exist in different forms with distinct acceptor glycolipid specificities and coded for by different genes expressed tissue-specifically. In fact, al-2 fucosyltransferase activity has been mapped to two genes, the Se and H genes Kelly et al., 1994; Rouquier et al., 1995) , respectively, where the product of the former prefers type 1 chain and the latter type 2 chain glycolipid precursors (Holgersson et al., 1992) . They exhibit tissuespecific expression patterns where the Se gene is preferentially expressed in endodermally and the H gene in ectodermally derived tissues (Holgersson et al., 1992) . Different, tissuespecific forms of the A'-acetylgalactosaminyltransferase has not been identified, although allelic variants of the A gene encoding this enzyme exist (Yamamoto et al., 1992 (Yamamoto et al., , 1993a . Another blood group system, the Lewis system, is related to the ABO blood group system because the ABH and Lewis epitopes are formed on common core structures and some antigenic structures may contain mixed blood group ABH and Lewis determinants (Holgersson et al., 1992) . The expression of Lewis structures is determined by an (a 1-3/4 fucosyltransferase (Kukowska-Latallo et al., 1990) , which belongs to a family of five different, but homologous al-3 fucosyltransferases having distinct acceptor carbohydrate specificities and tissue distribution (Goelz et al., 1990; Lowe et al, 1990; Weston et al., 1992a,b; Natsuka et aL, 1994; Sasaki et al., 1994) . If the regulation would be at the level of blood group determinant biosynthesis, one would expect, at least to some extent, to find precursor chains without blood group determinants in a tissue that expresses blood group ABH glycolipids on a particular precursor chain. Second, the biosynthesis of ABH glycolipids may instead be regulated at the level of the core saccharide chain such that some precursor chains predominate in a particular tissue. The glycosyltransferases responsible for the synthesis of blood group determinants would then use whatever precursor chain types are available in that tissue.
The pig is known to have a blood group AO system comparable to the ABO blood group system of humans (Bell, 1983) . It is a widely used animal in experimental surgery and has lately been suggested, and in fact used, as donor species in xenotransplantations (transplantation between species) with humans as recipients (Groth et al., 1994; Mbller, 1994) . We, and others, have therefore undertaken a thorough characterization of the expression of blood group glycolipids in different porcine tissues, and so far a good concordance between humans and pigs in terms of the tissue specific expression of A glycolipids with different chain types has been found (Sako et al, 1987; Holgersson et al., 1990c) .
This article describes the structural characterization of glycosphingolipids in isolated, small intestinal, epithelial cells from a single blood group A pig with emphasis on blood group ABH and related compounds. In order to investigate whether the observed predominance of blood group A glycolipids with type 1 chain was due to restricted specificities of the enzymes making up the A determinant or whether the regulation was at the level of core saccharide chain biosynthesis, in vitro biosynthetic experiments were performed using a crude microsomal fraction from isolated pig intestinal epithelial cells as enzyme source and pure and well-defined glycolipids as sugar acceptors.
Results
The glycolipid fraction containing one to approximately four sugar residues in the carbohydrate chain (Figure la, lane NP) was further separated by HPLC into 9 subtractions designated NP1-9 (Figure lb, lanes NP1-9). The structures identified, and the means by which they were identified (i.e., mass spectrometry, 'H NMR spectroscopy, and TLC immunostaining), are listed in Table I . The fraction containing four sugar residues and more (Figure la,c, lane P) was fractionated by HPLC into five subtractions (Figure lc, , and the structural characterization of these fractions and fraction 8 from the nonpolar glycolipids (NP8; Figure lb), will be described below. A total non-acid glycosphingolipid fraction was isolated from the residual stroma (Figure lc, lane R), but no further characterization of this fraction was undertaken.
The identification of blood group ABH precursor glycolipids with different core saccharide chains Thin-layer immunostaining revealed reactivity in the foursugar region with an anti-Lc 4 Cer antibody (Figure 2a , lanes NP8, NP, P, and PI) and an anti-Gb 4 Cer antibody (Figure 2c , lanes NP8 and NP). Probing TLC plates with a lectin, E.cristagalli, specific for nLc 4 Cer and IV 2 FucnLc 4 Cer (Figure 2b ) (Ehrlich-Rogozinski et al, 1987; Teneberg et al, 1994) or an antibody specific for nLc 4 Cer (not shown) (Young et al, 1981) revealed no reactivity with pig small intestinal, non-acid glycolipids. Neither could any reactivity be seen following staining with an anti-Gg 4 Cer antibody (Watarai et al, 1987) (Figure  2d ).
Mass spectrometry of the permethylated and permethylatedreduced fractions NP8 and PI established the presence of fragments consistent with a Hex-HexNAc-Hex-Hex as well as a HexNAc-Hex-Hex-Hex sequence (not shown). *H NMR of these fractions gave no conclusive spectra due to the small sample amounts available.
Structural characterization of blood group ABH and related glycosphingolipids
Among the fractions containing glycolipids with one to four sugar residues in the carbohydrate chain, mass spectrometry and : H NMR spectroscopy revealed the presence of a blood group A tetraglycosylceramide based on lactosylceramide (see Table I ). This structure has previously been identified in kidneys of blood group A pigs (Holgersson et al, 1990c) and its presence has also been suggested in human kidney vein tissue (Holgersson et al, 1990a) .
NP P NP 123456789 R PI P2 P3 P4 P5 Tl T2 T3 T4 T5 Fig. 1 . Thin-layer chromatography of non-acid glycosphingolipids isolated from the small intestinal epithelial cells (a, lanes NP and P) and the nonepithelia] stroma (c, lane R) of a blood group A pig. The epithelial cell glycosphingolipids were separated into a nonpolar (NP) and a polar (P) fraction, which were further fractionated by HPLC into nine (b, lanes NP1-9) and five (c, lanes Pl-5) subtractions, respectively. Total non-acid glycolipid fractions isolated from the small intestines of five additional blood group A pigs are shown for comparison (c, . The approximate number of sugar residues in the carbohydrate chains is given by the number to the left of the chromatograms. The structures identified in the different fractions are listed in Table I . 'Immunostaining was performed on the total polar (P) fraction and reactivity with the particular compound was assumed based on thin-layer mobility of reactive components in the total polar fraction (see Figure 3) . ''Not structurally characterized. c See Figure 3e . "Traces.°0
. not established with certainty.
Following immunostaining of TLC plates with different anti-A antibodies, several blood group A reactive components could be identified in the fraction containing glycolipids with more than 4 sugars in their carbohydrate chains (Figure 3a -e, lane P). The Dako anti-A and the anti-A type 1 chain specific antibodies exhibited a very similar staining pattern ( Figure  3a ,b). Reactivity was seen in the 4-, 6/7-, 8/10-, and 12/14-sugar regions on the TLC plate, with the predominant staining seen in the 6-sugar region. A similar, but generally weaker, staining was seen with an anti-A type 2 chain specific antibody except from the lack of reactivity in the 4-sugar region ( Figure  3c ). At least two blood group A compounds were identified in the 7-sugar region using antibodies specific for difucosyl type 1 chain A ( Figure 3d ) and type 3 and 4 chain A structures (Figure 3e ), respectively. The latter reactivity most likely corresponds to the type 4 chain blood group A heptaglycosylceramide initially identified in human kidney and erythrocytes (Clausen et al., 1984; Breimer and Jovall, 1985) . In addition, reactivity was seen in the 9-sugar region with the type 3 and 4 chain specific anti-A antibody ( Figure 3e ). No reactivity was seen using anti-Le x , -Le 3 ', -Le", or -Le b antibodies (not shown).
In order to structurally characterize the components present, individual components were isolated by HPLC. Five fractions were obtained (Figure lc, lanes Pl-5). Fraction PI was described above.
The 'H NMR spectra of fractions P2 and 3 were more or less identical. In the spectrum of fraction P3 ( Figure 4a ) four P-coupled signals at 4.22 (J 1>2 = 6.3 Hz), 4.26 (J u = 6.9 Hz), 4.51 (J li2 = 8.0 Hz), and 4.54 (J l>2 = 7.7 Hz) ppm and two a-coupled signals at 4.92 (J ia = 3.8 Hz) and 5.07 (J, 2 = 3.6 Hz) ppm were identified consistent with previously recorded spectra of the monofucosyl blood group A hexaglycosylceramide based on the type 1 chain (A-6-1) (Clausen et al., 1985b) . In addition to these signals, the spectrum of fraction P2 contained an, unassigned a-coupled signal at 5.02 ppm (not shown). The 'H NMR spectrum of fraction P4 (not shown) was dominated by signals corresponding to the A-6-1 structure, which was in agreement with the mass spectrum of the permethylated and reduced fraction P4, which has a monofucosylated hexaglycosylceramide with hydroxy 16:0 fatty acid as the most abundant molecular species (see below). However, additional weak signals just above the noise level could be anti-Lc^er E. cristagalli anti-Gg^Cer seen, supporting the presence of additional compounds in fraction P4 (not shown). The l H NMR spectrum of fraction P5 (not shown) revealed a complex pattern with signals consistent with the presence of at least three different blood group A glycosphingolipids, the type 4 chain blood group A heptaglycosylceramide (Clausen et aL, 1984 ) the difucosylated type 1 chain blood group A heptaglycosylceramide, ALe b (Clausen et al., 1985a) , and the type 2 chain-based blood group A octaglycosylceramide.
The mass spectra of permethylated fractions P2, P3, and P4
anti-A all types anti-A type 1 anti-A type 2 anti-A difuc. type 1 anti-A type 3/4 8/10
12/14 7 8/10 A6-1 P A6-1 P A6-2P A7-1P A7-4 P Fig. 3 . Thin-layer immunostaining of pig small intestinal glycolipids using different anti-blood group A antibodies. The polar fraction containing glycolipids wim four and more sugar residues (lane P) was subjected to immunostaining using mouse MAbs to blood group A of all types (A581; a), A type 1 (AH-21; b), A type 2 (HH-4; c), A difucosyl type 1 (or ALe , HH-3; d), and A type 3 and 4 (KB26.5; e). Appropriate reference glycolipids (1 p.g/lane) were included as positive controls.
all contained sequence ions corresponding to a HexNAc-(dHex-)Hex-HexNAc-Hex-Hex structure, with differences seen only in peaks derived from fragments containing parts of the ceramide. The spectrum of permethylated-reduced fraction P3 together with a simplified formula for interpretation is shown in Figure 4b . Peaks corresponding to sequence ions (m/z 189, 246, 262, 624, 640, 856, 1060, and 1264) , fatty acidcontaining immonium ions (m/z 1647-1703), and molecular ions (M-H( + (m/z 1931-1987) for a structure consistent with A-6-1 were easily identified (Figure 4b) . The peak at m/z 1635 is due to a fragment comprised of the entire molecule minus the fatty acids and ions at m/z 948 (h20:0) to 1004 (h24:0) are due to fragments comprised of the fatty acid, the two inner hexoses and part of the Af-acetylhexosamine, and support the NMRverified type 1 chain configuration in the blood group A hexaglycosylceramide (Breimer et al., 1979; Breimer, 1984) .
The mass spectrum of permethylated-reduced fraction P4 was very similar to the spectrum of fraction P3 with the hexaglycosylceramide as the major molecular species found, albeit with hydroxy 16:0 fatty acid being the most abundant fatty acid instead of hydroxy 24:0 (not shown). This is also consistent with the slower migration of this compound on the TLC plate (Figure lc, lanes P3 and P4 (upper band only), respectively). However, as shown by TLC (Figure lc, lane P4) and as indicated by NMR spectroscopy, this fraction contained one or more additional components. At higher evaporation temperatures the permethylatedreduced spectrum of fraction P4 contained two partially overlapping series of peaks corresponding to the immonium ions of a structure with two deoxyhexoses, two N-acetylhexosamines, three hexoses, and hydroxy fatty acids as well as a structure having one deoxyhexose, two A'-acetylhexosamines, four hexoses, and hydroxy fatty acids (not shown). Furthermore, ions explained by rearrangement fragments containing the fatty acid (mainly hydroxy 24:0), the two inner hexoses, the deoxyhexose and parts of the A'-acetylhexosamine, supports the presence of a difucosyl blood group A heptaglycosylceramide (ALe 1 *) structure (Holgersson et al, 1991b) . Ions originating in a similar fragmentation, but containing the fatty acid, three hexoses, and parts of an Nacetylhexosamine support the presence of a monofucosyl blood group A heptaglycosylceramide (A-7-4) (Holgersson et al., 1991a) .
The spectrum of the permethylated and permethylatedreduced fraction P5 (not shown) contained peaks that could be explained by structures consistent with the presence of monofucosyl type 4 chain blood group A heptaglycosylceramides (&-1A), difucosyl type 1 chain blood group A heptaglycosylceramides (ALe 1^, and monofucosyl blood group A octaglycosylceramides (A-8) (Table I) .
Biosynthesis in vitro of different core saccharide chains and blood group H and A determinants using a crude microsomal fraction from the epithelial cells as enzyme source. To examine whether the predominant expression of type 1 chain A glycolipids in the epithelial cells is due to the al-2fucosyl and/or the otl-3N-acetylgalactosaminyl transferase activities being restricted to the type 1 precursor chain (Lc 4 Cer) or if the regulation is at the level of precursor chain biosynthesis, biosynthetic experiments in vitro were performed using pure and well-characterized glycolipids as precursors and a microsomal fraction from isolated epithelial cells as enzyme source. A radioactive product was obtained in all cases when Lc 4 Cer, nLc 4 Cer, Gg4Cer, and a mix of Gb 5 Cer and Le*-5 were used as precursor glycolipids and GDP-[U-14 C]fucose as sugar donor (Figure 5a and c, lanes 1-4) . No radioactive product was seen when Le*-5 alone was used as precursor (not shown). Similarly, radioactive products were obtained following addition of N-acetylgalactosamine to blood group H glycolipids based on Lc 4 Cer, nLc 4 Cer, Gg 4 Cer, and Gb 5 Cer (Figure 5b,d, lanes A-D) .
The use of monoclonal antibodies for the detection and identification of biosynthetic products is limited by the possible reaction of the MAbs with the same structures derived from the tissue from which the crude enzyme preparation has been made (Holgersson et al, 1990b) . However, based on the knowledge of existing and previously characterized blood group glycolipids, only the addition of fucose to Lc 4 Cer and nLc 4 Cer can create alternative structures. Therefore, we focused our efforts on finding ways of differentiating between biosynthesized H-5-1 and Le"-5 as well as H-5-2 and Le x -5, which are the two known products that can be made from Lc 4 Cer and nLc 4 Cer, respectively. The biosynthetic products obtained following the addition of fucose to Lc 4 Cer and nLc 4 Cer, respectively, were identified by TLC following acetylation (Figure 6 ). The acetylated derivative of the biosynthetic product obtained following the addition of fucose to Lc 4 Cer (Figure 6a ,b, lane 2) has the same R f value on the TLC plate as acetylated H-5-1 (Figure 6a , lane 1). Furthermore, the Le*-5 glycolipid is known to give rise to two different isomers following acetylation that migrates differently on the TLC plate ( Figure 6a These experiments indicated that the predominant expression of type 1 chain A glycolipids was not due to a restricted precursor chain usage by the a 1-2 fucosyl-and a 1-3 Nacetylgalactosaminyl transferase activities. Therefore, the in vitro biosynthesis of the Lc 4 Cer, nLc 4 Cer, and Gg^er precursor chains was investigated. Gg4Cer could not be made from Gg 3 Cer (not shown). However, a radioactive product migrating in the 4-sugar region on the TLC plate was obtained when Lc 3 Cer was used as precursor and UDP-[U-I4 C]galactose as sugar donor (Figure 7a, lane 1) . In contrast to the Lc 3 Cer precursor, which migrates as a double band (Figure 7b ), the product migrated as a triplet (Figure 7a, lane 1) . This migration pattern can therefore not be entirely explained by a heterogeneity in the ceramide part, but must be due to different linkage positions or configurations of the added galactose. The slowmigrating component in the triplet was completely removed, and the intermediate component was reduced in intensity, following cleavage of the radioactive product with 3-galactosidase (EC 3.2.1.23) from S.pneumoniae under conditions known to give complete and specific cleavage of galactose linked 31-4 ( Figure 7a, lane 2) . In parallel experiments one aliquot of the radioactive tetraglycosylceramide product was incubated with (-galactosidase and one without, and then in parallel passed through separate Sep-Pak cartridges. The methanol fractions were counted in a (-scintillation counter, and the percentage cleaved product was calculated. Approximately 40% of the product formed following addition of a galactose to the I^Cer precursor was cleaved by fi-galactosidase (EC 3.2.1.23) from S.pneumoniae, indicating that a substantial amount of nLc 4 Cer (type 2 chain core) can be made in vitro using an enzyme preparation derived from a tissue that expresses mainly type 1 chain glycolipids. The anomeric region of the 500 MHz proton NMR spectrum of the native glycolipid fraction P3 together with a structural formula for interpretation (a). 437 scans were collected from 600 jig of sample at a probe temperature of 30°C. In (b) the mass spectrum of the permethylated and reduced glycolipid fraction P3 is shown together with a simplified formula for interpretation. Conditions of analysis were: sample amount, 10 (J.g; electron energy, 75 eV; trap current, 500 (JLA; acceleration voltage, 8 kV; ion source temperature, 360°C.
Discussion
The predominance of type 1 chain ABH and related antigens in the epithelial cells of porcine small intestine is in agreement with the situation in humans, where it has been shown that the small intestinal epithelial cells express ABH and Lewis antigens on type 1 core chains according to the blood group ABH, Lewis and secretor phenotypes of the donors (Bj6rk et al., 1987) . The pig seems to express roughly the same types of different A glycolipids in its intestine as found in human intestine, except the A-7-4 structure which has not yet been identified in human small intestine (Holgersson et al, 1992) . This similarity in terms of blood group AH antigen expression is true also for kidneys (Holgersson et al, 1990c (Holgersson et al, , 1991a . As shown in previous studies for other species, e.g., human (Bjork et al, 1987) , rat (Breimer et al., 1982) , and mouse (Umesaki et al, 1981; Leffler et al, 1986) , there is a clear difference in the expression of glycolipids in the epithelial cells as compared to the residual stroma. It has been claimed that pig RBC express an A glycolipid based on the ganglio-series backbone (Sako et al, 1987) . However, no reactivity was seen upon immunostaining of glycolipids isolated from pig small intestine, pancreas, RBC, kidney, gall bladder, heart, and liver with an antibody specific for the blood group A determinant on the ganglioseries backbone (Holgersson et al., unpublished observations) . In terms of the complexity of blood group AH glycolipids found as well as the tissue distribution of A glycolipids with different chain types, the pig seems to be a suitable experimental animal for studies on the significance and regulation of the tissue-specific expression of blood group glycolipids (Holgersson et al., 1990a (Holgersson et al., , 1991a (Holgersson et al., , 1992 BjSrk et al., 1987; Backer et al, unpublished observations) . Studies on the glycosylation patterns in different pig organs should also benefit from the fact that the pig might become a future donor species in human xenotransplantaion-a situation in which the significance of carbohydrate antigens is well established (Moller, 1994) . Because the expression of blood group ABH glycolipids in the small intestine of humans is almost exclusively, except some immunological reactivity to type 2 chain glycolipids, confined to type 1 chains (BjOrk et al., 1987) , we initiated this study to see if this was the case also for pig small intestine. If so, could this be explained by a restricted acceptor glycolipid specificity of the a 1-2 fucosyl-and a 1-3 N-acetylgalactosaminyl transferase activities or is the regulation at the level of precursor chain biosynthesis? Although immunological reactivity was found to A glycolipids based on all four chain types (Figure 3 ), the type 1 chain A hexaglycosylceramide was extremely predominant because it was the major glycolipid of the epithelial cells as assessed by TLC, and the only component detected in that size interval using J H NMR spectroscopy (Figure 4a ) and mass spectrometry (Figure 4b ). This is also in concordance with the presence of the type 1 chain precursor, Lc 4 Cer, and the apparent absence of the type 2 chain precursor, nLc 4 Cer, as established by probing TLC plates with the TE-3 antibody (Figure 2a) and the E.cristagalli lectin (Figure 2b) , respectively.
Biosynthetic experiments in vitro were performed to address the question regarding a possible restricted acceptor specificity of the enzymes responsible for making the A determinant All precursor chains, Lc 4 Cer, nLc 4 Cer, Gg 4 Cer, and Gb 5 Cer, could act as acceptors for a fucose residue under the conditions used, although the efficiency of the Lc 4 Cer precursor was lower than for the others (Figure 5a,c) . This has been noticed before and has been explained by its low solubility in water-based solutions in spite of the presence of detergent (Henry, et ai, 1997) . Similarly, the blood group H structures based on these core chains could serve as acceptors for an A^-acetylgalactosamine residue (Figure 5b,d ). The conclusion from these results is that there does not seem to be any clear restrictivity of the enzymes making up the A determinant with respect to the precursor chains used. The a 1-2 fucosyl transferase activity has been ascribed to two different genes in humans, the H and die Se genes Kelly et ai, 1994; Rouquier et al., 1995) . The Se gene is in humans expressed mainly in endodermally derived tissues, such as die mucosa of the gastrointestinal tract (Holgersson et ai, 1992) . It can use both type 1 and 2 chain precursors (Holgersson et al., 1992) , in concordance with the results obtained here. Unexpectedly, however, Lc 3 Cer seemed to be elongated to both Lc 4 Cer and nLc 4 Cer following incubation with the enzyme preparation and UDP-[U- of the EDTA released cells used for the biochemical studies. Several reasons for the discrepancy between the results of the enzymatic and the biochemical studies can be thought of. First, the specificity of the p-galactosidase used to establish the identity of the biosynthesized product may not have been restricted to the Gal(31,4GlcNAc linkage. However, this is unlikely since the conditions for complete cleavage of Gaipi,4GlcNAc without any cleavage of Gaipi,3GlcNAc were established in trials using pure, nonradioactive Lc 4 Cer and nLc 4 Cer. Second, the biosynthesis of Lc 4 Cer and nLc 4 Cer in the intact cell might be compartmentalized in such a way that LcjCer never encounter the pi-4 galactosyltransferase (Luzio and Banting, 1993; Pel- ham and Munro, 1993) . Third, the activity of the pl-3 galactosyltransferase may be less specific when extracted from its natural environment in the intact cell, adding the galactose residue also in a fJl^l configuration when used in vitro. Of course, this could also explain the lack of restrictivity seen for the al-2 fucosyl-and al-3 N-acetylgalactosaminyltransferases as well.
The advances made in the molecular cloning of different glycosyltransferases, e.g., the blood group O and A gene encoded transferases (Yamamoto et al., 1990a,b) , should give us unique possibilities to study the acceptor glycolipid specificities of these enzymes. Two major strategies can be foreseen. First, the cDNA for, for instance, an al-2 fucosyl transferase can be introduced in a cell type having a particular set of precursor chains and the changes obtained in the glycosylation pattern can be biochemically characterized. Second, soluble and secreted forms of the glycosyltransferases can be genetically engineered to give large quantities of pure enzyme for in vitro biosynthetic experiments (Weinstein et al., 1987) . Together with insights into the transcriptional regulation of glycosyltransferase genes, this should give us a deeper understanding of how the tissue-specific expression of blood group glycolipids is accomplished and the biological significance of it
Materials and methods

Isolation of small intestinal epithelial cells
Small intestinal epithelial cells from a single blood group A pig (typed on its RBO were released from the residual stroma by a slight modification of the method of Weiser (Weiser 1973; Breimer et aL. 1981) The intestine was rinsed with physiological saline and then sequentially incubated with Weiser solution A (96 mM NaCl, 1.5 mM KC1, 27 mM sodium citrate, 8 mM KH 2 PO 4 , and 5.6 mM Na 2 HPO 4 , pH 7.3) followed by several incubations with solution B (137 mM NaCl, 3 mM KC1, 1.5 mM KH 2 PO 4 , 6.5 mM Na^HPO,, 1.5 mM EDTA, and 0.5 mM DTT, pH 7.3) keeping the intestine immersed in a 37°C waterbath. Recovered cells were washed with PBS, cenfrifuged, and stored at -80°C. The residual stroma, following EDTA-mediated release of the epithelial cells, was stored separately at -80°C. From a part of the intestine, the epithelial cells were mechanically scraped off, washed in PBS and stored at -80°C.
Gtycosphingolipid isolation and fractionation
Non-acid glycolipids were isolated from the residual stroma according to Karlsson (Karlsson, 1987) , and from a volume of epithelial cells corresponding to 250 mg of total protein (BCA protein assay reagent; Pierce Chemical Co., Rockford, IL) using purification steps including extraction, methanolysis, DEAE-cellulose column chromatography, and acetylation followed by chromatography on a silicic acid column (Breimer et aL, 1981) . Three fractions were obtained from the latter column, the first containing acetylated nonpolar lipids and glycoupids with one to four sugar residues, the second containing acetylated glycolipids with four and more sugars and the third consisting of acetylated sphingomyelin. The glycolipids having one to four sugars were separated from the nonpolar lipids on a silicic acid column following deacetylation, and further fractionated by HPLC on a 4 x 250 mm silicic acid column (Spherisorb; S10W, Phase Sep, Clwyd, UK) using a gradient of chloroform/ methanol/water, 80:20-1 to 40:40:12 (by volume) over 50 rain and a flow rate of 0.5 ml/min. Glycolipids with four and more sugars were fractionated by HPLC after deacetylation, using conditions as above but a gradient of chloroform/methanol/water, 65:25:4 to 40:40:12 (by volume).
Glycolipid characterization
TLC was performed on HPTLC plates (Si-60; Merck, Darmstadt, Germany; HP-KF, Whatman, Maidstone, UK) using chloroform/methanol/water, 60:35:8 (v/v/v), as solvent. Detection was accomplished by anisaldehyde (Karlsson, 1987) or by autoradiography following incubation of the plates with MAbs or lectins according to a modification of the method of Magnani (Magnani et aL, 1980; Hansson et al., 1983; Torres et aL, 1988) . Antibodies and lectins used were: anti-H and anti-A (A583 and A581, respectively; Dakopatts, Denmark) (Holgersson etaL, 1988) , anti-A type 1 (AH21) (Abe ctaL, 1984), anti-A type 2 (HH4) (Clausen et aL, 1986) , anti-A type 3 and 4 (KB-26.5) (LePendu et aL, 1986) , anti-A difucosyl type 1 (HH3; anti-ALe 1 ") (Clausen et aL, 1986) , anti-AGA, (MH-3;anti-A Gg^Cer) (White, Hakomori, and Clausen unpublished observations), anti-Le* (XALA; Chembiomed, Canada) (Holgersson et aL, 1990a) , anti-Le b (9ALB; Chembiomed, Canada) (Holgersson et aL, 1990a), anti-Le* (SHI) (Singhal, Nance, and Hakomori, unpublished observations), anti-Le*' (AH-6) (Abe et aL, 1984) , anti-Lc 4 Cer (TE 3) (Holmes and Greene, 1990) , HMST-1 (Nozawa et aL, 1989) , anti-Gb 4 Cer (CLB-ery-2) (von dem Bome et aL, 1986) , anti-nlx 4 Cer (1B2) (Young et aL, 1981) , anti-asialo GM, (anti-G&Cer, AG1, Seikagaku Corp., Japan) (Watarai et aL, 1987) , and the Erythrina cristagaili lectin (Ehrlich-Rogozinski et al., 1987; Teneberg et al.. 1994) .
Proton NMR spectroscopy of native glycolipids and direct inlet El mass spectrometry of permethylated and permethylated-reduced glycolipids were performed as described (Holgersson et aL, 1990b) .
Glycolipid biosynthesis
A crude microsomal fraction to be used as enzyme source was prepared from mechanically or enzymatically released epithelial cells (Samuelsson, 1984; Holgersson et aL, 1990b) . The protein concentration of the two enzyme preparations were 20.3 and 32.6 mg/ml, respectively (BCA protein assay reagent; Pierce Chemical Co., Rockford, EL). The precursor glycolipids were: Lc 4 Cer from human meconium (Karlsson and Larson, 1979) , nLc 4 Cer from desialylated sialylparagloboside (TV 3 NeuNAcnLc 4 Cer) from human RBC or dog small intestine (Samuelsson et al., unpublished observations), Gg 3 Cer, G^Cer, and rV 2 FucGg 4 Cer from mouse small intestine (Hansson et aL, 1982; Umesaki et aL, 1989) , IV 3 GalGb 4 Cer and V 2 FucIV 3 GalGb 4 Cer from human kidney (Holgersson et aL, 1991a) , rV 2 FucLc 4 Cer from pig small intestine (Holgersson et aL, 1990b) , IV 2 FucnLc 4 Cer from dog small intestine (McKibbin, 1978) and Lc 3 Cer from human malignant melanoma (Karlsson et aL, unpublished observations) . The precursor glycolipids (50-100 (ig) were incubated with 65 |il of the enzyme preparation, 3.7 GBq UDP-[U-
M C]galactose, UDP-Af-acetyl-D-[ll4 C]galactosamine or GDP-[U-14 C]fucose (Du Pont NEN, Boston, MA), 10 (jJ 1 M Tris-HCl (pH 8.0), 1 u.mol ATP, 3 ujnol MnCl 2 (or 3 pjnol MgCl 2 in the fucosyltransferase assay), 1 junol NaN 3 , and 0.1 % Triton X-100 at 37°C for 48 h (Samuelsson, 1984; Holgersson et aL. 1990b) . The reaction products were extracted and passed through a prewashed C18Sep-Pak cartridge (Waters Associates) as described (Holgersson et aL. 1990b) . The radiolabeled products were identified by TLC followed by autoradiography.
Biosynthetic product identification
The tetraglycosylceramide product obtained following incubation of Iactotriaosylceramide with UDP-[U-
M C]galactose was digested with f5-galactosidase (EC 3.2.1.23) from S.pneumoniae (Oxford GlycoSystems Ltd., Oxon, UK) according to the instructions from the manufacturer. Conditions were chosen to maintain GalBl-4GlcNAc/GalNAc specificity, i.e., keeping the enzyme concentration <100 mU/ml, and to accomplish complete cleavage of neolactotetraosylceramide (nLc 4 Cer). Briefly, approximately 1/10 of the tetraglycosylceramide product, corresponding to 2 ng of precursor glycolipid, was evaporated and dissolved in 20 |xl of 0.1% Triton X-100, 0.2 ml 5x incubation buffer (500 mM sodium acetate, pH 6.0), and 0.3 ml of distilled water. B-Galactosidasc (40 mU in 0.5 ml) in incubation buffer (100 mM sodium acetate, pH 6.0 with 200 jig/ml BSA) was added and the vial was incubated at 37°C for 24 h. The reaction products were extracted and passed through a prewashed C18Sep-Pak cartridge (Waters Associates) as described previously (Holgersson et al., 1990b) . To estimate the percentage of radioactive tetraglycosylceramide product that was cleaved following incubation with B-galactosidase, two parallel incubations were made-one with, and one without, B-galactosidase-and passed through separate Sep-Pak cartridges. An aliquot of the methanol fractions (Holgersson et al., 1990b) was counted in a B-scintillarion counter, and the percentage cleaved tetraglycosylceramide product was calculated.
Addition of a fucose residue to lactotetraosylceramide (Lc 4 Cer) or neolactotetraosylceramide (nLc 4 Cer) can give rise to four known structures, H-5-1 (IV 2 FucLc 4 Cer) or Le'-5 (m 4 FucLc 4 Cer), and H-5-2 (IV 2 FucnLc 4 Cer) or Le*-5 (III 3 FucnLc 4 Cer), respectively. In order to distinguish between these structures and to identify the products obtained following the biosynthetic addition of fucose to Lc 4 Cer and nlx 4 Cer, the radioactive products were dissolved in chloroform, and pyridine and acetylated using acetic acid anhydride (Saito and Hakomori, 1971) . Pyridine was added to buffer the acetic acid formed. The acetylation reaction was stopped by the addition of methanol and toluene, and the samples were dried under a stream of nitrogen. Acetylated samples were analyzed by TLC using chloroform/methanol, 95:5 (by volume), as solvent. Anisaldehyde and autoradiography were used for detection.
